MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913,140 | -24.3% | 91,314 | -5.9% | 0.00% | 0.0% |
| Q2 2023 | $1,206,804 | -13.7% | 97,088 | -2.7% | 0.00% | -25.0% |
| Q1 2023 | $1,398,478 | -8.4% | 99,820 | -6.4% | 0.00% | -20.0% |
| Q4 2022 | $1,526,033 | -47.3% | 106,641 | -6.0% | 0.01% | -44.4% |
| Q3 2022 | $2,896,000 | -15.5% | 113,425 | -6.0% | 0.01% | 0.0% |
| Q2 2022 | $3,428,000 | -3.4% | 120,666 | +19.9% | 0.01% | +28.6% |
| Q1 2022 | $3,550,000 | +532.8% | 100,658 | +651.7% | 0.01% | +600.0% |
| Q4 2021 | $561,000 | -10.2% | 13,390 | +5.2% | 0.00% | 0.0% |
| Q3 2021 | $625,000 | +66.2% | 12,731 | +41.3% | 0.00% | 0.0% |
| Q2 2021 | $376,000 | +22.1% | 9,011 | +4.4% | 0.00% | 0.0% |
| Q1 2021 | $308,000 | – | 8,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |